Researchers develop 3D bioprinting technology for eliminating cancer cells

FHS
July 12, 2023
3:19 am

A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for the first time in the world.

How health tech startups survived 2023 despite a 4-year funding low

(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.) To survive, health tech startups got creative

January 9, 2024

Mutation Linked to Increased Risk of Prostate Cancer Mortality

The risk of dying of prostate cancer doubled in the presence of a genetic mutation affecting testosterone production, a large prospective cohort study showed. The

March 21, 2024

Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS) – Biotech Investments

Takeda Pharmaceutical Company Limited / Key word(s): Forecast Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS) 30-Jan-2025 /

January 31, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.